Arcus Biosciences (RCUS) has a market capitalization of $2.9B, based on 125.77M shares at a price of $23.19 (down 4.4% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
June 2026 | $23.19 | 5,254,000 | 125,773,164 | $2,916,679,673.16 |
May 2026 | $25.34 | 19,040,900 | 125,773,164 | $3,187,091,975.76 |
April 2026 | $25.50 | 27,447,100 | 125,773,164 | $3,207,215,682.00 |
March 2026 | $21.60 | 28,619,758 | 125,000,000 | $2,700,000,000.00 |
February 2026 | $20.37 | 20,246,203 | 125,000,000 | $2,546,250,000.00 |
January 2026 | $21.04 | 27,219,355 | 125,000,000 | $2,630,000,000.00 |
December 2025 | $23.83 | 47,071,586 | 107,000,000 | $2,549,810,000.00 |
November 2025 | $26.10 | 35,371,785 | 107,000,000 | $2,792,700,000.00 |
October 2025 | $19.72 | 35,396,728 | 107,000,000 | $2,110,040,000.00 |
September 2025 | $13.60 | 18,888,600 | 107,000,000 | $1,455,200,000.00 |
August 2025 | $10.59 | 15,739,900 | 107,000,000 | $1,133,130,000.00 |
July 2025 | $9.13 | 16,119,900 | 107,000,000 | $976,910,000.00 |
June 2025 | $8.14 | 24,432,897 | 107,000,000 | $870,980,000.00 |
May 2025 | $8.93 | 25,308,200 | 107,000,000 | $955,510,000.00 |
April 2025 | $8.75 | 27,899,308 | 107,000,000 | $936,250,000.00 |
March 2025 | $7.85 | 19,558,352 | 98,000,000 | $769,300,000.00 |
February 2025 | $10.89 | 25,027,701 | 98,000,000 | $1,067,220,000.00 |
January 2025 | $12.90 | 12,359,661 | 98,000,000 | $1,264,200,000.00 |
December 2024 | $14.89 | 14,509,166 | 90,000,000 | $1,340,100,000.00 |
November 2024 | $15.44 | 15,704,971 | 90,000,000 | $1,389,600,000.00 |
October 2024 | $15.30 | 18,302,430 | 90,000,000 | $1,377,000,000.00 |
September 2024 | $15.29 | 10,655,275 | 91,000,000 | $1,391,390,000.00 |
August 2024 | $17.12 | 14,158,395 | 91,000,000 | $1,557,920,000.00 |
July 2024 | $16.41 | 11,270,075 | 91,000,000 | $1,493,310,000.00 |
June 2024 | $15.23 | 19,336,127 | 91,000,000 | $1,385,930,000.00 |